Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults - Ma, Joseph D.; Nafziger, Anne N.; Villano, Stephen A.; Gaedigk, Andrea; Bertino, Joseph S. (Antimicrobial Agents and Chemotherapy, 2006)
Keywords: Adult; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral Agents; Antiviral Agents - pharmacology; Aryl Hydrocarbon Hydroxylases - metabolism; Arylamine N-Acetyltransferase - metabolism; Benzimidazoles; Benzimidazoles - pharmacokinetics; Benzimidazoles - pharmacology; Biological and medical sciences; Cytochrome P-450 CYP1A2 - metabolism; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6 - metabolism; Cytochrome P-450 CYP3A - metabolism; Double-Blind Method; Drug Interactions; Humans; Medical sciences; Mixed Function Oxygenases - metabolism; Pharmacology. Drug treatments; Ribonucleosides; Ribonucleosides - pharmacokinetics; Ribonucleosides - pharmacology; Therapeutic Equivalency; Xanthine Oxidase - metabolism; Human; Acyltransferases; Enzyme; Transferases; Arylamine N-acetyltransferase; Biological activity; Multiple dose; Maribavir; Adult; Antiviral; Xanthine oxidase; Oxidoreductases; Pharmacokinetics